Prognostic Significance of Statin Use in Colorectal Cancer
نویسندگان
چکیده
منابع مشابه
Prognostic Significance of Statin Use in Colorectal Cancer
Statin intake has been reported to reduce the risk of several malignancies beyond its cholesterol-lowering effects. However, little is known regarding the survival benefit of statins for patients with colorectal cancer (CRC).We conducted a systematic literature search of multiple databases for studies published before November 2014, which investigated associations between statin intake and CRC ...
متن کاملprognostic significance of nuclear β-catenin expression in patients with colorectal cancer from iran
background beta catenin plays a key role in cancer tumorigenesis. however, its prognostic significance in patients with colorectal cancer (crc) remains controversial. it has been demonstrated that 90% of all tumors have a mutation in individual components of multiple oncogenes in wnt/β-catenin pathway. accumulation of nuclear β-catenin in cytoplasm leads to uncontrolled cell proliferation. thus...
متن کاملPrognostic Significance of CD26 in Patients with Colorectal Cancer
BACKGROUND CD26, dipeptidyl peptidase IV, was discovered firstly as a membrane-associated peptidase on the surface of leukocyte. We previously demonstrated that a subpopulation of CD26+ cells were associated with the development of distant metastasis, enhanced invasiveness and chemoresistance in colorectal cancer (CRC). In order to understand the clinical impact of CD26, the expression was inve...
متن کاملPrognostic significance of serum miR-193b in colorectal cancer
Circulating microRNAs (miRNAs) have been demonstrated to be potential diagnostic and prognostic markers for many types of cancers including colorectal cancer (CRC). The aim of current study was to determine the clinical significance of serum miR-193b in CRC. The expression of serum miR-193b in CRC patients and healthy controls was detected by quantitative reverse transcription-polymerase chain ...
متن کاملPrognostic significance and targeting of HER family in colorectal cancer.
Colorectal cancer is one of the leading causes of cancer deaths. At present, anti-epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) cetuximab and panitumumab and anti-vascular endothelial growth factor (VEGF) mAb bevacizumab have been incorporated into treatment paradigms for patients with refractory metastatic colorectal cancer. However, many patients simply do not respond t...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2015
ISSN: 0025-7974
DOI: 10.1097/md.0000000000000908